Gemcitabine - Eli Lilly and Company/Genentech
At a glance
- Drug Originator Eli Lilly and Company; Genentech; University of Innsbruck
- Drug Licenced by Cheplapharm Arzneimittel
- Drug Class Amines; Antineoplastics; Deoxyribonucleosides; Fluorinated hydrocarbons; Ketones; Pyrimidine nucleosides; Pyrimidines; Small molecules
- Mechanism of Action Antimetabolites; DNA synthesis inhibitors
- USA Patent Applicants LILLY
- USA Patents 2
- NDAs 1
- Patent Applications 7,517
Table of Contents
Disclaimer